CURALEAF HOLDINGS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.87 USD | +4.82% |
|
+9.93% | +44.58% |
| 05-10 | Needham Adjusts Price Target on Curaleaf to $6.25 From $5.25, Keeps Buy Rating | MT |
| 05-10 | Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Curaleaf Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
70ec3.JDXxY3huf8ZJ37ikyfobDlzeIEe1gPmDK_MblwPDDbc.e0PcAE1WKK4nvtPmvopqZ3GYajPT5J7pGsQi0Um3d4FxYoQKPVcIhQW02w~6ffc914267c37587764c4c55c6a99e52
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
5.868
USD
Average target price
8.426
USD
Spread / Average Target
+43.58%
High Price Target
17.22
USD
Spread / Highest target
+193.36%
Low Price Target
4.827
USD
Spread / Lowest Target
-17.74%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Curaleaf Holdings, Inc.
| Needham & Co. |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- CURA Stock
- CURLF Stock
- Consensus Curaleaf Holdings, Inc.